QALY = quality-adjusted life year; ICER = incremental cost-effectiveness ratio; base = cheapest alternative; dom = dominated. Results are shown as means and 95% credibility intervals.
IntroductionPatients with a penicillin allergy label (PAL) use more and broader-spectrum antibiotics, have worse health outcomes and cost more to treat than patients without a PAL. A significant propo
